About Rossari Biotech Ltd
Rossari Biotech is mainly engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products.
Founded
2009
CEO
Edward Menezes
Employees
1,278
HQ
Mumbai, India
Finished Products
1Sale of Products
₹4,955.90Cr2Chemicals-Traded
₹1,411.80Cr3Other Operating Income
₹47.09Cr4Adjustments
₹19.83CrRaw Materials
1Cost of Materials consumed
₹1,890.42Cr2Agro Origin
₹1,066.43Cr3Purchase of Traded Goods
₹1,062.07Cr4Acetic &CitricAcid
₹811.12CrAbout Rossari Biotech Ltd
Rossari Biotech is mainly engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products.
Founded:2009
CEO:Edward Menezes
Employees:1,278
HQ:Mumbai, India
Finished Products
1Sale of Products
₹4,955.90Cr2Chemicals-Traded
₹1,411.80Cr3Other Operating Income
₹47.09Cr4Adjustments
₹19.83CrRaw Materials
1Cost of Materials consumed
₹1,890.42Cr2Agro Origin
₹1,066.43Cr3Purchase of Traded Goods
₹1,062.07Cr4Acetic &CitricAcid
₹811.12CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹690
52W Low
₹375
Volume47.96K
Avg VolumeN/A
Beta1.19
Dividend Yield0.11%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
17.49x
Valuation
P/B Ratio
1.98x
Valuation
EPS
₹27.21
Valuation
Dividend Yield
0.11%
Valuation
ROE
11.19%
Profitability
ROCE
13.06%
Profitability
Revenue by Segment
Contribution & growth by business line
Specialty chemicalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
74.4%
International
25.6%
India74.4%
Outside India25.6%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.33x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
9.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.